BD Announces $110 Million to Support U.S. Pharmaceutical Supply Chain for Biologic Drugs

URLhttps://news.bd.com/2026-01-13-BD-Announces-110-Mi
SourcePRNewswire
Date Published01/13/2026

Additional Reshoring Information:

Company/Division name BD (Becton, Dickinson and Company)
Parent companyBD (Becton, Dickinson and Company)
Type of work Manufacturing
Reshoring category:Reshoring
Total number of jobs (added or to be added):120
Year reshoring announced:2026
Year reshoring implemented or to be implemented:2030
Capital investment ($):110
City reshored to:Columbus
State(s) reshored to:NE
If relevant, work nearshored to:-
Industry(ies):Medical Equipment & Supplies
Product(s) reshoredmedical equipment
What non-domestic negative factors made offshoring less attractive?Supply chain interruption
What domestic positive factors made reshoring more attractive?Eco-system synergies, Impact on domestic economy, Lean/other business process improvement techniques, Manufacturing/engineering joint innovation (R&D), Proximity to customers/market, Skilled workforce availability/training
Find Reshoring Articles